Bioglan Pharma sells GenPlus to Ethercorp

British pharmaceutical company, Bioglan Pharma, which runs offices in Dublin and Clonmel, has sold its UK-based telesales business…

British pharmaceutical company, Bioglan Pharma, which runs offices in Dublin and Clonmel, has sold its UK-based telesales business GenPlus Ltd.

Genplus is the first of Bioglan's non-core business activities to be sold following a decision by the company to focus on its core areas of dermatology and the development of its Biosphere drug delivery system.

It has been purchased by Ethercorp for a sum described as "nominal".

Ethercorp will now assume responsibility for PenPlus’ capital arrangements including paying off the associated overdraft.

David Labanyi

David Labanyi

David Labanyi is the Head of Audience with The Irish Times